January 28, 2015 12:08 PM ET


Company Overview of Cerimon Pharmaceuticals, Inc.

Company Overview

Cerimon Pharmaceuticals, Inc. develops and commercializes therapeutics for autoimmune diseases, inflammation, and pain in the United States and Europe. It develops Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, including pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. Cerimon Pharmaceuticals, Inc. was founded in 2004 and is headquartered in San Francisco, California.

701 Gateway Boulevard

Suite 100

South San Francisco

San Francisco, CA 94080

United States

Founded in 2004





Key Executives for Cerimon Pharmaceuticals, Inc.

Co-Founder and Director
Age: 56
Age: 51
Senior Vice President of Pharmaceutical Product Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Ruga Corporation United States
BioZone Laboratories, Inc. United States
Contract Pharmacal Corp. United States
Bio-Pharm, Inc. United States
Animal Health Associates, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cerimon Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.